Showing results (261-270 of 436) with videos related to
Sort By:
Pageof 44
AIDS (London, England)|February 1, 1988
Characterization of a monoclonal antibody specific for the HIV-1 precursor glycoproteinB Krust, A G Laurent, A Le Guern, et al.Blood Purification|January 1, 1992
Dose of dialysis: what index?B Charra, E Calemard, C Chazot, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 27, 1999
L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generationN Andrieu-Abadie, J P Jaffrezou, S Hatem, et al.The Biochemical Journal|October 12, 2000
Phosphatidylcholine-specific phospholipase C and phospholipase D are respectively implicated in mitogen-activated protein kinase and nuclear factor kappaB activation in tumour-necrosis-factor-alpha-treated immature acute-myeloid-leukaemia cellsI Plo, D Lautier, T Levade, et al.Annual Review of Neuroscience|April 3, 2001
Odor encoding as an active, dynamical process: experiments, computation, and theoryG Laurent, M Stopfer, R W Friedrich, et al.AIDS Research and Human Retroviruses|February 1, 1992
Antiviral action of polyadenylic-polyuridylic acid against HIV in cell culturesA G Laurent-Crawford, B Krust, E Deschamps de Paillette, et al.The Journal of Biological Chemistry|October 15, 1991
Reversal of multidrug resistance by calcium channel blocker SR33557 without photoaffinity labeling of P-glycoproteinJ P Jaffrézou, J M Herbert, T Levade, et al.Journal of Virology|February 1, 1990
Transmembrane envelope glycoproteins of human immunodeficiency virus type 2 and simian immunodeficiency virus SIV-mac exist as homodimersM A Rey, A G Laurent, J McClure, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 26, 1998
Positive feedback control of neutral sphingomyelinase activity by ceramideJ P Jaffrézou, N Maestre, V de Mas-Mansat, et al.Annales D'Anatomie Pathologique|January 1, 1977
[Dysimmunologic and pseudolymphomatous adenopathies. II. Lymphadenopathies rich in epithelial cells]G Delsol, J Familiades, J J Voigt, et al.Pageof 44